REGENERON PHARMACEUTICALS, INC. REGN 53.43
Health Care · NASDAQ · Data as of 2026-07-30
REGENERON PHARMACEUTICALS, INC. (REGN) has delivered +15.0% annualized revenue growth, +19.3% earnings growth, and n/a dividend growth over 10 years of data. Ranked #768 of 1993 stocks overall and #78 of 264 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
53.43
Overall Rank
#768 / 1993
Sector Rank
#78 / 264
Revenue CAGR
+15.0%
Earnings CAGR
+19.3%
Dividend CAGR
-
?
E/R CAGR Ratio
1.3x
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio